Read + Share
Zaqout A, Almaslamani MA, Chemaitelly H, Hashim SA, et al. Effectiveness of the neutralizing antibody sotrovimab among high-risk patients
with mild-to-moderate SARS-CoV-2 in Qatar. Int J Infect Dis 2022;124:96-103.
PMID: 36218031
|
 |
|
Zaqout A, Almaslamani MA, Chemaitelly H, Hashim SA, et al. Effectiveness of the neutralizing antibody sotrovimab among high-risk patients
with mild-to-moderate SARS-CoV-2 in Qatar. Int J Infect Dis 2022;124:96-103.
PMID: 36218031
|
|
|
|